Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter Serno is active.

Publication


Featured researches published by Peter Serno.


Journal of Pharmaceutical and Biomedical Analysis | 2013

Development and in-line validation of a Process Analytical Technology to facilitate the scale up of coating processes.

Markus Wirges; Adrian Funke; Peter Serno; Klaus Knop; Peter Kleinebudde

Incorporation of an active pharmaceutical ingredient (API) into the coating layer of film-coated tablets is a method mainly used to formulate fixed-dose combinations. Uniform and precise spray-coating of an API represents a substantial challenge, which could be overcome by applying Raman spectroscopy as process analytical tool. In pharmaceutical industry, Raman spectroscopy is still mainly used as a bench top laboratory analytical method and usually not implemented in the production process. Concerning the application in the production process, a lot of scientific approaches stop at the level of feasibility studies and do not manage the step to production scale and process applications. The present work puts the scale up of an active coating process into focus, which is a step of highest importance during the pharmaceutical development. Active coating experiments were performed at lab and production scale. Using partial least squares (PLS), a multivariate model was constructed by correlating in-line measured Raman spectral data with the coated amount of API. By transferring this model, being implemented for a lab scale process, to a production scale process, the robustness of this analytical method and thus its applicability as a Process Analytical Technology (PAT) tool for the correct endpoint determination in pharmaceutical manufacturing could be shown. Finally, this method was validated according to the European Medicine Agency (EMA) guideline with respect to the special requirements of the applied in-line model development strategy.


Journal of Pharmaceutical Sciences | 2013

Monitoring of an Active Coating Process for Two-Layer Tablets-Model Development Strategies

Markus Wirges; Adrian Funke; Peter Serno; Klaus Knop; Peter Kleinebudde

Incorporation of an active pharmaceutical ingredient (API) into the coating layer of film-coated tablets is a method mainly used to formulate combination tablets. Uniform and precise spray coating of an API represents, however, a substantial challenge that could be overcome by applying Raman spectroscopy as process analytical tool. In the present work, active-coating experiments for osmotic-controlled-release oral delivery system (OROS) tablets were performed in a side-vented lab-scale pan coater. During the process, Raman spectra were recorded in-line and off-line after sampling. Quantitative multivariate calibration models were built up by correlating these spectra with the coated API amount at each sampling point. Three different modeling approaches were tested on a second batch with regard to their predictive ability and robustness. By applying the in-line model development approach on OROS tablets, it was possible to overcome the difficulties of this dosage form with each layer contributing differently to the resulting spectroscopic signal and to determine accurately the applied API amount on two-layer tablets. Thereby, the present study demonstrated that Raman spectroscopy can be successfully implemented as a process analytical technology tool to control and monitor an active-coating process of OROS tablets.


Archive | 2006

Pharmaceutical forms with improved pharmacokinetic properties

Peter Serno; Roland Heinig; Kerstin Pauli; Yutaka Hayauchi


Archive | 2006

Combination for the therapy of benign prostatic hyperplasia

Helmut Haning; Peter Serno; Erwin Bischoff


Archive | 1998

2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren

Erwin Bischoff; Klaus Dembowsky; Mazen Es-Sayed; Helmut Haning; Jörg Keldenich; Ulrich Niewöhner; Marc Nowakowski; Elisabeth Perzborn; Thomas Schenke; Karl-Heinz Schlemmer; Peter Serno


Archive | 2017

uso e regime de aplicação de uma composição farmacêutica contendo levonorgestrel e um inibidor de cox para a contracepção necessária ("on demand")

Bernhard Lindenthal; Katrin Waellnitz; Peter Serno; Stefanie Lindemann; Ulrike Fuhrmann


Archive | 2015

Metodo para anticoncepcion controlada que comprende administrar una preparacion farmaceutica que comprende levonorgestrel y un inhibidor de la cox; uso de la composicion farmaceutica en la anticoncepcion "a la carta".

Bernhard Lindenthal; Katrin Waellnitz; Peter Serno; Stefanie Lindemann; Ulrike Fuhrmann


Archive | 2014

COMPOSICIÓN FARMACÉUTICA, SU USO Y RÉGIMEN DE ADMINISTRACIÓN PARA CONTRACEPCIÓN PROGRAMADA

Bernhard Lindenthal; Bernd Buchmann; Anne Mengel; Andrea Rotgeri; Antonius Ter Laak; Ulrike Fuhrmann; Nico Dr Bruer; Ulrike Dr Rhn; Peter Serno


Archive | 2014

Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception

Bernhard Lindenthal; Nico Bräuer; Peter Serno; Andrea Rotgeri; Ulrike Fuhrmann; Bernd Buchmann; Anne Mengel; Ulrike Röhn; Antonius Ter Laak


Archive | 2013

USE AND APPLICATION REGIMEN OF A PHARMACEUTICAL COMPOSITION CONTAINING LEVONORGESTREL AND A COX INHIBITOR FOR ON-DEMAND CONTRACEPTION

Bernhard Lindenthal; Katrin Waellnitz; Peter Serno; Stefanie Lindemann; Ulrike Fuhrmann

Collaboration


Dive into the Peter Serno's collaboration.

Researchain Logo
Decentralizing Knowledge